| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 10/10/2007 | CN101050193A Nitric ester derivatives, its medicinal composition and their medicinal use |
| 10/10/2007 | CN101049296A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases |
| 10/09/2007 | US7279581 Diazotization of 4-(1,2,4-triazol-1-ylmethyl)phenylamine hydrochloride, reduction and acidification, reaction with hydrazine hydrochloride and alpha -keto- delta -valerolactone, Fischer indole reaction, hydrolysis, transesterification, conversion of hydroxyl group to dimethylamino group |
| 10/09/2007 | US7279580 For prophylaxis and therapy of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders |
| 10/09/2007 | US7279489 Compounds and methods for modulation of estrogen receptors |
| 10/09/2007 | US7279486 Therapy and prophylaxis of pain, central nervous system diseases; 2-Benzyl-3-(2,3-dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)propanoic acid trifluoroacetate |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/09/2007 | US7279314 Chemical substance having morphogenetic and growth-accelerating activities |
| 10/09/2007 | US7279264 fluorescein dyes that exhibit a first color when in the crystal structured form and a second color when in the liquid, amorphous form, for use in thermal printing |
| 10/09/2007 | CA2195428C Water-soluble esters of camptothecin compounds |
| 10/04/2007 | WO2007111203A1 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 10/04/2007 | WO2007063385A3 Spirocyclic amine histamine-3 receptor antagonists |
| 10/04/2007 | WO2007022351A3 Muscarinic acetylcholine receptor antagonists |
| 10/04/2007 | US20070232630 MACROCYCLE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE) |
| 10/04/2007 | US20070232604 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors |
| 10/04/2007 | US20070232600 Anti-migraine treatments |
| 10/04/2007 | US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof |
| 10/04/2007 | US20070232585 Sigma Receptor Inhibitors |
| 10/04/2007 | US20070232533 Use of Vinca Alkaloids and Salts Thereof |
| 10/04/2007 | DE102006015456A1 Bicyclische Enamino(thio)carbonylverbindungen Bicyclic enamino (thio) carbonyl compounds |
| 10/04/2007 | CA2648025A1 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 10/03/2007 | EP1839659A2 Chemicals compounds |
| 10/03/2007 | EP1838863A1 Methods for the production of ansamitocins |
| 10/03/2007 | EP1838715A2 Method for the preparation of maytansinoid esters |
| 10/03/2007 | EP1838324A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 10/03/2007 | EP1838152A2 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 10/03/2007 | EP1751157B1 Inhibitors of the hiv integrase enzyme |
| 10/03/2007 | EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament |
| 10/03/2007 | EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 10/03/2007 | CN101048390A Heterocyclical chromophore architectures |
| 10/03/2007 | CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 10/02/2007 | US7276530 Lactam fermentation products, e.g., pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane or cyclohexane ring, used as antimicrobial, anticancer or antiinflammatory agents; treating drug resistant cancer |
| 10/02/2007 | US7276524 Compounds as antumor agents or immunosuppressants |
| 10/02/2007 | US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity |
| 10/02/2007 | US7276512 anti-tumour properties; surprising in vitro and in vivo cytotoxic activity |
| 10/02/2007 | US7276184 Surfactant assisted nanomaterial generation process |
| 10/02/2007 | CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 10/02/2007 | CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation |
| 09/27/2007 | WO2007109661A2 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities |
| 09/27/2007 | WO2007109334A2 Sip receptor modulating compounds and use thereof |
| 09/27/2007 | WO2007107005A1 Inhibitors of protein tyrosine kinase activity |
| 09/27/2007 | WO2007025009A3 Indenoisoquinolinone analogs and methods of use thereof |
| 09/27/2007 | US20070225314 Novel forms of tiotropium bromide and processes for preparation thereof |
| 09/27/2007 | US20070225313 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 09/27/2007 | US20070225289 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 09/27/2007 | US20070225271 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 09/27/2007 | US20070225266 Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections |
| 09/27/2007 | US20070224552 Process for the preparation of novel dyes for use in imaging members |
| 09/27/2007 | CA2679980A1 S1p receptor modulating compounds and use thereof |
| 09/27/2007 | CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 09/26/2007 | EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
| 09/26/2007 | CN100339375C Metabolites of ecteinascidin 743 |
| 09/26/2007 | CN100339352C 2-and 2,5-substituted phenylketoenols |
| 09/25/2007 | US7273873 Camptothecins with a modified lactone ring |
| 09/25/2007 | US7273859 Spiro-alkane, -tetrahydrofuranfuran, -tetrahydropyran, -pyrrolidine or -piperidine fused ring pyrimidinonecarboxamides, e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-4'-oxo-spiro[cyclopentane-21,9'(6'H)-[4H]pyrido[1,2- alpha ]pyrimidine]-2'-carboxamide |
| 09/25/2007 | CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them |
| 09/20/2007 | WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library |
| 09/20/2007 | WO2007105729A1 Process for production of cyclopropylamide compound |
| 09/20/2007 | WO2007105658A1 Process for producing optically active chromene oxide compound |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | WO2007104214A1 Camptothecin derivatives and their use |
| 09/20/2007 | WO2007079715A3 Novel lysolipin derivatives |
| 09/20/2007 | US20070219219 Methods of Preparation and Resolution of E/Z Isomers of Vinylfuro[2,3-D]Pyrimidine and their Biological Activities and related compositions and methods of treatment |
| 09/20/2007 | US20070219218 Compounds for the treatment of inflammatory disorders |
| 09/20/2007 | US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd |
| 09/20/2007 | US20070219212 Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease |
| 09/20/2007 | US20070219203 Arylalkylamino-substituted quinazoline analogues |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070219179 Indole Derivative Having Piperidine Ring |
| 09/20/2007 | CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | CA2646223A1 Novel heterocyclic nf-kb inhibitors |
| 09/20/2007 | CA2645683A1 Process for producing optically active chromene oxide compound |
| 09/19/2007 | EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
| 09/19/2007 | EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | CN101039947A Inhibitors of hcv replication |
| 09/19/2007 | CN100338066C Hexacyclic compounds |
| 09/19/2007 | CN100338057C Halogenated nitrobutadienes for controlling animal pests |
| 09/18/2007 | US7271265 Cyanine compounds and their application as quenching compounds |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271173 Mixed kappa/mu opioids and uses thereof |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271165 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 25-O-deacetyl-25-(2'',3''-dihydroxypropylcarbonoxy)-5'-[4-isobutyl-1-piperazinyl]benzoxazinorifamycin |
| 09/18/2007 | US7271159 Camptothecin analogs and methods of preparation thereof |
| 09/18/2007 | US7270772 Benzopyran colorants, method of manufacture, and method of use |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102467A1 Aqueous solution of conophylline and/or conophyllidine |
| 09/13/2007 | WO2007087204A3 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia |
| 09/13/2007 | US20070213525 meridamycin derivatives used as neuroprotectants, prepared by reacting meridamycin with a dialkoxyalkane in the presence of an acid catalyst, then reacting the with the periodinane and treating with tetrapropylammonium ruthenate and N-morpholine oxide; polyketides |
| 09/13/2007 | US20070213353 Esters in position 20 of camptothecins |
| 09/13/2007 | US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213320 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1831228A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 09/12/2007 | EP1831227A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 09/12/2007 | EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |